“…Recently, the treatment of spinal cord injury (SCI) has undergone novel changes in concept, though the disease still remains incurable (22,27,28). New research is largely being conducted in studies of clinical cell therapies [bone marrow (BM) or peripheral blood mononuclear cells (PBMNCs), olfactory ensheathing cells (OECs), and Schwann cells (SCs)] (9,19,31,37,46,54,63,66,71,75), growth factors [e.g., brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3)] (5,20,52,74), inhibitory molecules [e.g., NG2 (also known as chondroitin sulfate proteoglycan 4; CSPG4), myelin protein) (17,50,65), and combination therapies (e.g., cell grafts, neurotrophins, cotransplantation) (12,32,47,51,53).…”